All slots are booked for the doctor today. Please check for another day or call us at 011 - 49674967.
Next Available Slot
Request Call Back
Doctor Consultation Charges (Video Consultation) - Rs. Price not Available/-
Confirm Appointment
Are you new to hospital?
Go Back
Your appointment is confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Your Appointment will be confirmed after generating Pre Registration ID and making payment for consultation now.
Patient Registration Details
1
Basic Details
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
2
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
Other Details
3
Declaration
Consent and Declaration
I, the undersigned, declare that the above information provided by me are true to the best of my knowledge and hereby provide my consent to the Manipal Hospital to provide Medical Care, Treatment, Conduct Investigations and Diagnostic Procedures necessary for the above mentioned individual by Medical Staff at Manipal Hospital. I, also understand that Manipal Hospital will not be responsible for any loss, damage or theft of any Personal Property/Belongings of Me/Patient/Visitors within the Hospital Premises. Including Patients rooms and Parking area. I agree to follow all the rules and regulations of Hospital and clear all the expenses incurred for My/Patient treatment on time as per the Terms and Conditions of Manipal Hospital,
I would like to receive Self/Patient reports by Email
I would like to receive Hospital Info Alerts reports by Email
If consent provided on behalf of the patient.
I hereby give my consent and authorize Manipal Hospitals to process, store,use,disclose my personal or sensitive information/data collected as per Manipal Privacy Policy
Go Back
We have sent you an OTP on
+91 8745360000
Resend OTP
Did not receive OTP? You can request for another OTP click resend option
Go Back
Patient Details
Confirm Appointment
Are you new to hospital?
Go Back
Go Back
Your Appointment will be confirmed after generating Pre Registration ID and making payment for consultation now.
Patient Registration Details
1
Basic Details
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
2
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
Other Details
3
Declaration
Consent and Declaration
I, the undersigned, declare that the above information provided by me are true to the best of my knowledge and hereby provide my consent to the Manipal Hospital to provide Medical Care, Treatment, Conduct Investigations and Diagnostic Procedures necessary for the above mentioned individual by Medical Staff at Manipal Hospital. I, also understand that Manipal Hospital will not be responsible for any loss, damage or theft of any Personal Property/Belongings of Me/Patient/Visitors within the Hospital Premises. Including Patients rooms and Parking area. I agree to follow all the rules and regulations of Hospital and clear all the expenses incurred for My/Patient treatment on time as per the Terms and Conditions of Manipal Hospital,
I would like to receive Self/Patient reports by Email
I would like to receive Hospital Info Alerts reports by Email
If consent provided on behalf of the patient.
I hereby give my consent and authorize Manipal Hospitals to process, store,use,disclose my personal or sensitive information/data collected as per Manipal Privacy Policy
Go Back
We have sent you an OTP on
Resend OTP
Did not receive an OTP? You Can Request For Another OTP Click Resend Option
Go Back
Patient Details
×
ALREADY APPOINTMENT IS AVAILABLE FOR THIS PATIENT
×
We see that your email address is not updated in our system. Hence, we couldn't able to complete this transaction.We request you to call our appointment helpline number: 1800 102 5555 to book an appointment.
The Mobile Number entered is not registered with Manipal Hospitals.
To continue, re-enter your Registered Mobile Number or Generate Pre Registration ID and make payment for the Doctor Appointment.
The entered UHID Number is not registered with Manipal Hospitals.
To continue, re-enter your Register or Generate Pre Registration ID and make payment for the Doctor Appointment.
₹ 1100--
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
Go back to change your appointment slot
We have sent you an OTP on
+91 8745360000
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
Life Member- Society of Nuclear Medicine India (SNMI).
Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
Field of Expertise
Radionuclide scans & Therapy
Languages Spoken
English
Hindi
Awards & Achievements
“Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
“Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
Talks & Publications
Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Languages Spoken
English
Hindi
Fellowship & Membership
Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
Life Member- Society of Nuclear Medicine India (SNMI).
Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
Field of Expertise
Radionuclide scans & Therapy
Awards & Achievements
“Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
“Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
Talks & Publications
Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Field of Expertise
Radionuclide scans & Therapy
Fellowship & Membership
Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
Life Member- Society of Nuclear Medicine India (SNMI).
Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
Languages Spoken
English
Hindi
Awards & Achievements
“Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
“Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
Talks & Publications
Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Awards & Achievements
“Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
“Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
Fellowship & Membership
Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
Life Member- Society of Nuclear Medicine India (SNMI).
Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
Field of Expertise
Radionuclide scans & Therapy
Languages Spoken
English
Hindi
Talks & Publications
Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Talks & Publications
Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at International conference of radiopharmaceutical therapy (ICRT) held at Vienna, Austria in 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India conference (SNMICON) held at Ahmedabad in December 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic oesophagal and gastro-oesophagal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuro-endocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of the primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.
Fellowship & Membership
Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon, and GOSH, London in 2014.
Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015.
Awarded “Fellowship by Singapore Nuclear Medicine Society” during Annual conference held in Singapore in August 2017.
Awarded “Fellow of Asian Nuclear Medicine Board (FANMB)” by the Asian Nuclear Medicine board in Shanghai, China in May 2019.
Life Member- Society of Nuclear Medicine India (SNMI).
Member- World Association of radiopharmaceutical therapy (WARMTH)Member- European Association of Nuclear Medicine (EANM).
Field of Expertise
Radionuclide scans & Therapy
Languages Spoken
English
Hindi
Awards & Achievements
“Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
“Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).
Best Paper award in SNMICON 2010, Indian Cancer Congress (2013).
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.